Archive for January 2017
Say Hello to Your Body’s Newest Organ: The Mesentery
Over a century ago, when scientists were classifying the body’s organs, one was short shrifted, according to researchers who say part of the digestive system deserves to be upgraded to organ status. In a new medical journal report, scientists say the mesentery – connective tissue that winds around our digestive organs, holding them in place –…
Read MoreTerumo, Xenex Ink Japanese Distro Deal for LightStrike Room Disinfection Robot
Terumo Corp. (TYO:4543) said today it inked a Japanese distribution deal with Xenex to distribute its Xenex LightStrike Germ-Zapping Robots in the region. The LightStrike device is designed to use pulsed xenon ultraviolet room disinfection technology to remove pathogens such as C. diff, staphylococcus aureus and carbapenem-resistent Enterobacteriaceae, Terumo said. The Xenex LightStrike device has also…
Read MoreDePuy Synthes Strategic Acquisition to Accelerate Growth in Spine
RAYNHAM, Mass., Jan. 3, 2017 /PRNewswire/ — DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, announced today an asset purchase and development agreement with Interventional Spine, Inc., a privately held manufacturer of expandable cage and minimally invasive surgery (MIS) technologies for spinal fusion. The Interventional Spine agreement is the latest example…
Read MoreAbbott Labs Plans to Wrap Up St. Jude Medical Deal Jan. 4
Abbott Laboratories intends to close its deal to buy medical device maker St. Jude Medical just after the new year, now that it has received permission from U.S. and international antitrust regulators scrutinizing the $25 billion acquisition. Abbott Labs, in suburban Chicago, said Friday it intends to wrap up the deal on Jan. 4; originally,…
Read MoreBionic Pancreas System Successfully Controls Blood Sugar Without Risk of Hypoglycemia
The bionic pancreas system developed by Boston University (BU) investigators proved better than either conventional or sensor-augmented insulin pump therapy at managing blood sugar levels in patients with type 1 diabetes living at home, with no restrictions, over 11 days. The report of a clinical trial led by a Massachusetts General Hospital (MGH) physician is receiving advance…
Read More